Patent details
EP1381432 Title: HSA-free formulations of interferon-beta.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP1381432
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Expired. Art. 36.6 ROW
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP01988466.7
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
-
300546
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 26/10/2001
- Grant date:
- 15/02/2012
- EP Publication Date:
- 15/02/2012
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 15/02/2012
- EP B1 Publication Date:
- 15/02/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- 15/02/2012
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 25/10/2021
- Lapsed By Expiration Date:
- 26/10/2021
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 03/05/2017
- Name:
- GlaxoSmithKline Biologicals S.A.
- Address:
- Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)
Historical Applicant/holder
- From:
- 15/02/2012
- To:
- 03/05/2017
- Name:
- Novartis Vaccines and Diagnostics, Inc.
- Address:
- 4560 Horton Street, EMERYVILLE, CA 94608, United States of America (US)
Inventor
1
- Name:
- SHIRLEY, Bret, A., Chiron Corporation
- Address:
- EMERYVILLE, CA 94662-8097, United States of America (US)
2
- Name:
- CHOE, Minna, Chiron Corporation
- Address:
- EMERYVILLE, CA 94662-8097, United States of America (US)
3
- Name:
- TELLERS, Melanie, Chiron Corporation
- Address:
- EMERYVILLE, CA 94662-8097, United States of America (US)
4
- Name:
- BABUKA, Susan, Chiron Corporation
- Address:
- EMERYVILLE, CA 94662-8097, United States of America (US)
5
- Name:
- CHEN, Bao-Lu, Novartis Vaccines and Diagnostics, Inc.
- Address:
- EMERYVILLE, CA 94608-2916, United States of America (US)
6
- Name:
- HORA, Maninder, Novartis Vaccines and Diagnostics, Inc.
- Address:
- EMERYVILLE, CA 94608-2916, United States of America (US)
Priority
1
- Priority Patent Number:
- 35397
- Priority Date:
- 25/10/2001
- Priority Country:
- United States of America (US)
2
- Priority Patent Number:
- 330404 P
- Priority Date:
- 18/10/2001
- Priority Country:
- United States of America (US)
3
- Priority Patent Number:
- 282614 P
- Priority Date:
- 09/04/2001
- Priority Country:
- United States of America (US)
Classification
- Main IPC Class:
- A61K 38/21;
- IPC or IDT classification:
- A61K 9/08; A61K 47/12; A61K 47/16;
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 43/21
- Publication date:
- 27/10/2021
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- CO
- Journal edition number:
- 30/17
- Publication date:
- 26/07/2017
- Description:
- Changes in the Netherlands Patent Register
3
- Bulletin Heading:
- EP3
- Journal edition number:
- 2012/09
- Publication date:
- 29/02/2012
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
4
- Bulletin Heading:
- EP2
- Journal edition number:
- 2012/08
- Publication date:
- 22/02/2012
- Description:
- European patents granted for the Netherlands
5
- Bulletin Heading:
- EP1
- Journal edition number:
- 2011/33
- Publication date:
- 17/08/2011
- Description:
- Translations of the claims of European patent applications
European Patent Bulletin
1
- Issue number:
- 201217
- Publication date:
- 25/04/2012
- Description:
- Document reprinted after correction (B8, B9)
2
- Issue number:
- 201207
- Publication date:
- 15/02/2012
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC201700993C
- Date Registered:
- 03/05/2017
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- GlaxoSmithKline Biologicals S.A.
- Address:
- Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 18/09/2020
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 1400 Euro
- Payer:
- Master Data Center
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 21/07/2017 | Outgoing Correspondence | Letter registration deed | 2 | /6/6/4/8/8/0501988466/docs/ep01988466.7_14_151768l118.pdf | ||
| 03/05/2017 | Request for Change | First filed deed | 3 | /6/6/4/8/8/0501988466/docs/ep01988466.7_4_rfc20170531112953333.pdf | ||
| 27/04/2012 | Incoming Correspondence Paper | Other | 1 | /6/6/4/8/8/0501988466/docs/ep01988466.7_9_incomingcorrespondencepaper20120427.pdf | ||
| 15/02/2012 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /6/6/4/8/8/0501988466/docs/ep01988466.7_0_incomingcorrespondencepaper20120215.pdf | ||
| 15/02/2012 | Outgoing Correspondence | Outgoing Letter | 1 | /6/6/4/8/8/0501988466/docs/ep01988466.7_3_outgoingcorrespondence20120215.pdf | ||
| 15/02/2012 | Drawings | First filed drawings | 28 | /6/6/4/8/8/0501988466/docs/ep01988466.7_7_drawings20120215.pdf | ||
| 15/02/2012 | Claims | Translated claims | 9 | /6/6/4/8/8/0501988466/docs/ep01988466.7_11_claims20120215.pdf | ||
| 15/02/2012 | Description | Translated description | 37 | /6/6/4/8/8/0501988466/docs/ep01988466.7_12_description20120215.pdf | ||
| 17/10/2011 | Outgoing Correspondence | Outgoing Letter | 1 | /6/6/4/8/8/0501988466/docs/ep01988466.7_2_outgoingcorrespondence20111017.pdf | ||
| 17/10/2011 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /6/6/4/8/8/0501988466/docs/ep01988466.7_6_incomingcorrespondencepaper20111017.pdf | ||
| 17/10/2011 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /6/6/4/8/8/0501988466/docs/ep01988466.7_10_incomingcorrespondencepaper20111017.pdf | ||
| 17/10/2011 | Claims | Translated claims | 8 | /6/6/4/8/8/0501988466/docs/ep01988466.7_13_claims20111017.pdf | ||
| 04/08/2011 | Incoming Correspondence Paper | Accompanying letter incoming document | 2 | /6/6/4/8/8/0501988466/docs/ep01988466.7_1_incomingcorrespondencepaper20110804.pdf | ||
| 04/08/2011 | Outgoing Correspondence | Outgoing Letter | 1 | /6/6/4/8/8/0501988466/docs/ep01988466.7_5_outgoingcorrespondence20110804.pdf | ||
| 04/08/2011 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /6/6/4/8/8/0501988466/docs/ep01988466.7_8_incomingcorrespondencepaper20110804.pdf | ||
| 04/08/2011 | Claims | Translated claims | 24 | /6/6/4/8/8/0501988466/docs/ep01988466.7_15_claims20110804.pdf |